Stelara (ustekinumab) Disease area(s): Immunology Manufacturer(s): Johnson & Johnson 2024 Sales (USD): $10.36 billion Why it sold so well: J&Js immunology blockbuster Stelara generated approximately $10.36 billion in global sales in 2024, a 4.6% decline from the previous year
Most women who begin tirzepatide treatment through a medically supervised program describe a gradual but meaningful shift in how they relate to food, specifically, a reduction in the constant background noise of hunger that can make every day feel like a battle
Skin Density and Hair Quality (Weeks 8 to 16) IGF-1 drives collagen synthesis and fibroblast activity
Improves nerve function Help manage the symptoms of peripheral neuropathy Promote red blood cell production
Side effects and practical notes Nausea is the most common side effect, especially in the first four weeks
In the absence of specific vaccines and anti-SARS-CoV-2 drugs, medicines that may reduce the severity of the disease and limit the high number of fatalities are urgently needed
